Therefore, also in the periphery, BE mucosal abnormality, a clearly recognized risk factor for EAC development, is associated with altered plasmatic ENO1 levels that may predate the clinical diagnosis of malignancy. The gene discussed is ENO1; the disease is Barrett esophagus.